Colorblind Watercolor Artist Sells His NFTs to Fund Longevity Researchers Research.

Share on facebook
Share on twitter
Share on linkedin
Share on pinterest
Social Chats
Share on facebook
Share on twitter
Share on linkedin
Share on pinterest

We had an opportunity to chat with Adam Stewart, an American nomad watercolor and Sumi (Japanese ink) artist/poet teaching English while residing in Laos via Twitter Spaces. He had donated proceeds valued at 9.3 Etherium($40K+) from the sales of his 2Tulips NFT series to three longevity researchers.

Twitter Spaces:

Our founder/broadcaster, Tonya Scholz, and Co-host, Brian, had a chat with NFT artist Adam Stewart and Bobby Brooke & Dr. Greg Fahy of Intervene Immune (interveneimmune.com) about their longevity research on thymus regeneration and immune monitoring program. This episode was originally live-streamed via Twitter Space Saturday, November 13 @ 6 PM PST | 9 PM EST

Colorblind watercolor artist Adam Stewart shares with us how he came to conceive his #2Tulips series of three #NFTs: • 2Tulips: Proof of Work • 2Tulips: Proof of Storage • 2Tulips: Proof of Burn.

#NFTsLongevityProjects(EPS 1): Why Crypto & Longevity by Adam Stewart.

Adam explains the 2Tulips series of three #NFTs: • 2Tulips: Proof of Work • 2Tulips: Proof of Storage • 2Tulips: Proof of Burn.

the 2Tulips series of three NFTs: • 2Tulips: Proof of Work • 2Tulips: Proof of Storage • 2Tulips: Pr

Brian chatted w/ Adam about creating the 2Tulips Series of three #NFTs! #NFTsLongevitySpace

The Process to create 2Tulips Series of Three NFTs.

Intervene Immune Longevity Project: Thymus Regeneration

Robert (Bobby) Brooke, CEO & CTO, Co-founder Intervene Immune, shared his thought on why he and Dr. Greg Fahy joined forces to launch Intervene Immune.

#NFTsLongevityProjects Eps. 1: Robert (Bobby) Brooke, CEO & CTO, Co-founder Intervene Immune

Brian chatted with Bobby Brooke, Co-Founder of Intervene Immune, dedicated to reversing a process called “thymic involution” in people about the TRIIM trials results.

#NFTsLongevityProjects  (EP 1): Intervene Immune TRIIM Trials

Brian asks Greg Fahy, Ph.D., Chief Scientific Officer, Co-founder Intervene Immune, to further explain the TRIIM project and Thymus regeneration.

#NFTsLongevityProjects(EPS 1): Greg Fahy, PhD, Chief Scientific Officer, Co-founder Intervene Immune

Listen to a full episode #NFTsLongevityProjects (EPS 1):

Funding Longevity Research with NFT’s Proceeds. #NFTsLongevityProjects

Stay tuned for more episodes of #NFTsLongevityProjects, where we feature an NFT artist & the longevity researchers they are donating!

 

About Adam Stewart:

Adam Stewart is a nomad American watercolor and Sumi (Japanese ink) artist/poet teaching English while residing in Laos. Since age eight, Adam’s passion was to be an artist but was discouraged by colorblindness. He filled multiple passports as a traveling, homeless backpacker throughout Asia, including India, Sri Lanka, Nepal, Korea, Japan, Thailand, Cambodia, Vietnam, Laos, Myanmar, Indonesia, and the Philippines.  Six years ago, while working as an English headteacher at a school in Laos, Adam began focusing on perfecting his real addiction/obsession: his art. He has been a watercolor artist by trade full-time for three years. In 2020, Adam entered the Crypto world, conceiving and executing his #NFTsLongevityProjects. Today, he works as a full-time watercolor artist and hosts social audio Twitter Spaces to help other NFT artists.

For more info on Adam Stewart’s NFTs, go to:

Foundation App: foundation.app/@colorblind-creation

Social Networks: Twitter Facebook Instagram Youtube

 

About Intervene Immune:

Intervene Immune is dedicated to achieving a better understanding of the fundamental biology of aging and applying this new knowledge into the practice of medicine today.  For information, go to interveneimmune.com

Robert (Bobby) Brooke, CEO & CTO, Co-founder of Intervene Immune

-Managed TRIIM trial, including coordination of all regulatory approvals and collaborations

-Serial biotech entrepreneur: Founder of cancer immunotherapy company now known as Iovance Biotherapeutics (NASDAQ: IOVA),  Co-founder of cannabinoid drug development company, Vitality Biopharma

-Former hedge fund investment analyst with Bristol Capital Advisors, a direct investor in more than 50 healthcare and biotech companies

-Bioengineer from Georgia Tech & UCLA; Co-inventor on recent patent applications, including for GI-targeted drug delivery

Greg Fahy, Ph.D., Chief Scientific Officer, Co-founder of Intervene Immune

-Designed and led the TRIIM trial; Published the first report of thymus regeneration in a normal human; Granted patents on methods for and applications of human thymus regeneration

–Fellow of the American Aging Association (since 2005), Former Director of the American Aging Association (16 years)

–Editor-in-Chief, The Future of Aging: Pathways to Human Life Extension

–Awarded the Society for Cryobiology’s Luyet Medal in 2016

–In 2009, showed indefinite survival of rabbit kidney transplanted after cooling to -130° Celsius; Led 21CM team as co-winner of Small Mammal Brain Preservation Prize, 2018 winner of Large Mammal Brain Preservation Prize

Share on facebook
Share on twitter
Share on linkedin
Share on pinterest
WRITTEN BY
Social Chats

Social Chats is a multimedia and entertainment company. It’s a division of kNOw Aging, inc. a communications consultancy.

Leave a Reply

Receive the latest news

Subscribe To Our Weekly Newsletter

Get notified about new articles